Surat Store Owner Held For Selling NDPS Drugs Without Prescriptions

Surat : A medical store owner in Surat was arrested Wednesday for allegedly selling codeine cough syrup and Tramadol, Alprazolam tablets — categorised as sedative drugs — to customers without prescriptions.

According to personnel of the Surat city Special Operation Group (SOG) , some accused arrested for petty crimes were found to be addicted to codeine syrup, Tramadol and Alprazolam. On interrogation, the arrested persons disclosed that they bought the medicines from Pramukh Medical Store in Parvatgam area.

Acting on the information, SOG sleuths sent a dummy customer without doctor’s prescription to the medical store and purchased such tablets and cough syrups. Store owner Swarup Dewasi, who is a resident of Varachha road and native of Pali in Rajasthan, was taken into custody.

Police also seized 368 tablets of Alprazolam and 16 bottles of codeine cough syrup.

Surat city SOG inspector AP Chaudhary said, “Alprazoalm is used to treat anxiety disorder and panic disorder while codeine is used to treat mild and moderate pain. We have come across petty criminals addictive to these… The medical shop owner has been held and further probe is on.”

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March